₹ 247.95
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Samrat Pharmachem Ltd. is a company focused on the production and sale of various chemical compounds. Its product offerings feature substances like 3-5–Di iodosalicylic acid, aluminium iodide, clioquinol, ethylenediamine dihydroiodide, copper iodine, and lithium iodide. Lalit Damodar Mehta founded the enterprise on June 16, 1992, and it maintains its primary offices in Mumbai, India.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.
Data is available to registered users only